title: Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation.
authors.forename: M T
authors.initials: MT
authors.lastname: Lin
authors.forename: T
authors.initials: T
authors.lastname: Gooley
authors.forename: J A
authors.initials: JA
authors.lastname: Hansen
authors.forename: L H
authors.initials: LH
authors.lastname: Tseng
authors.forename: E G
authors.initials: EG
authors.lastname: Martin
authors.forename: K
authors.initials: K
authors.lastname: Singleton
authors.forename: A G
authors.initials: AG
authors.lastname: Smith
authors.forename: E
authors.initials: E
authors.lastname: Mickelson
authors.forename: E W
authors.initials: EW
authors.lastname: Petersdorf
authors.forename: P J
authors.initials: PJ
authors.lastname: Martin
mesh_terms: D000208:Acute Disease; D002908:Chronic Disease; D006086:Graft vs Host Disease / Q000453:epidemiology* / Q000209:etiology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000706:statistics & numerical data*; D006648:Histocompatibility; D006801:Humans; D015778:Minor Histocompatibility Antigens / Q000032:analysis* / Q000235:genetics / Q000276:immunology; D009842:Oligopeptides / Q000032:analysis* / Q000235:genetics / Q000276:immunology; D012008:Recurrence; D012306:Risk; D016019:Survival Analysis; D014019:Tissue Donors; D014184:Transplantation, Homologous / Q000009:adverse effects / Q000706:statistics & numerical data*; D016896:Treatment Outcome
chemical_list: C110615:HA-1 antigen; D015778:Minor Histocompatibility Antigens; D009842:Oligopeptides